Search
for
Did you mean Plasminogen Activator Inhibitor-1?
Sort by
Research 30 of 354
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Urokinase plasminogen activator (uPA) is a positive regulator of outer root sheath keratinocyte proliferation
- Transient Ca2+ entry by plasmalogen-mediated activation of receptor potential cation channel promotes AMPK activity
- Proteomics Characterization of Primary Human Oral Epithelial Cells Using a Novel Culture Technique for Use in Tissue Regeneration
- Wound healing in development
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo
- Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering
- Matriptase: Potent Proteolysis on the Cell Surface
- Defining stem cell dynamics and migration during wound healing in mouse skin epidermis
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Forsythiaside A protects against focal cerebral ischemic injury by mediating the activation of the Nrf2 and endoplasmic reticulum stress pathways
- The PDGF/PDGFR pathway as a drug target
- Follikelhormone
- LH Induces Murine Hair Loss through TRPC-Medicated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis
- The hair growth promoting effect of extract and its molecular regulation
- Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier
- Matriptase Expression and Zymogen Activation in Human Pilosebaceous Unit
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- JMJD3 and NF-κB-dependent activation of Notch1 gene is required for keratinocyte migration during skin wound healing
- Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic risk in PCOS: phenotype and adiposity impact
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management